Bicycle Therapeutics
This role serves as the operational engine bridging Research & Innovation and Clinical Development, overseeing the day-to-day coordination and tracking of the therapeutic portfolio. The incumbent manages integrated Gantt charts, orchestrates meeting agendas, maintains risk registries, and ensures seamless execution of project milestones within scope and budget. Working under Director-level leadership, the position requires translating complex scientific strategies into tangible, trackable plans while fostering cross-functional alignment.
Headquarters
Great Abington, England, United Kingdom
Company Size
201-500 employees
Founded
2009
Bicycle Therapeutics is a clinical-stage biopharmaceutical company that pioneers a proprietary "Bicycle" bicyclic peptide platform to create precision-guided therapeutics. Their modular, constrained peptides are engineered to bind targets with high affinity and can be formatted as multispecific agents or linked to payloads (e.g., cytotoxins or immune modulators) to enable targeted delivery, with a strong focus on oncology and other serious diseases. The company emphasizes rapid tissue penetration, scalable chemistry and strategic collaborations to advance a pipeline of targeted therapies toward clinical development.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bicycle Therapeutics.
Bicycle Therapeutics didn’t post a salary, so this is our estimate from similar listings.
15% below the average for this role